Sign in

CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
911911336
Phone
512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. S-3/A Offering Registration Statement
  2. UPLOAD Other SEC-generated Letter
  3. S-3 Offering Registration Statement
  4. DEF 14A Proxy Proxy Statement
  5. 10-K Report Annual Report
  6. 8-K Event Results of operations
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 4 Open-market buy President and CEO bought 100,000 shares at $5.53 ($553,000)
  16. 4 Open-market buy President and CEO bought 10,000 shares at $4.15 ($41,500)
  17. 4/A Open-market buy President and CEO bought 2,599 shares at $1.65 ($4,288)
  18. 4 Open-market buy President and CEO bought 2,599 shares at $1.65 ($4,288)
  19. 4 Open-market buy Director bought 423,788 shares at $2.20 ($932,334)
  20. 4 Open-market buy Chief Financial Officer bought 5,300 shares at $1.88 ($9,964)

Page 16 of 62 · 1,225 filings